Evaluation of the Anti-Inflammatory Activities of Diclofenac Sodium, Prednisolone and Atorvastatin in Combination with Ascorbic Acid

Author(s): Tanvir Ahmed, Sabrina Rahman Archie, Asef Faruk, Fabliha Ahmed Chowdhury, Abdullah Al Shoyaib, Chowdhury Rafiqul Ahsan*

Journal Name: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Formerly Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents

Volume 19 , Issue 3 , 2020

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Objectives: Inflammation is our body’s normal defense mechanism, but in some cases, it may be responsible for causing different kinds of disorders. Several antiinflammatory drugs are present for the treatment of these disorders; however, the conventional anti-inflammatory drugs cause side effects when used in the long term and therefore, it is better to use them in a low dose for a shorter duration of time. This study was designed to find out whether there is an augmentation of the therapeutic effectiveness of the antiinflammatory drugs like diclofenac sodium (NSAID), prednisolone (steroid) and atorvastatin (statin) when used in combination with ascorbic acid (antioxidant).

Methods: Wistar Rats (n=144) were selected and divided into 24 groups of 6 rats in each. Carrageenan and formalin were used to induce local inflammation and neuropsychiatric effects, respectively. The inhibitions of such responses were measured after administering a drug alone and in combination with ascorbic acid.

Results: In case of carrageenan mediated inflammation, the combination of 5 mg/kg diclofenac and 200 mg/kg ascorbic acid gave the highest inhibition of 74.19% compared to other groups of drugs. The combination of 5 mg/kg diclofenac and 200 mg/kg ascorbic acid gave 97.25% inhibition for formalin-mediated inflammation group. In both cases, combination therapy showed statistically significant anti-inflammatory activities compared to monotherapy (p values <0.05).

Conclusion: All the data clearly indicate new combinations of drug therapy comprising diclofenac sodium, prednisolone, atorvastatin with ascorbic acid, which may be more effective against both local edema and the neuropsychiatric effect caused due to inflammation.

Keywords: Ascorbic acid, atorvastatin, diclofenac sodium, inflammation, prednisolone, immunity.

[1]
Ahmed, A.U. An overview of inflammation: mechanism and consequences. Front. Biol., 2011, 6, 274-281.
[http://dx.doi.org/10.1007/s11515-011-1123-9]
[2]
Medzhitov, R. Origin and physiological roles of inflammation. Nature, 2008, 454(7203), 428-435.
[http://dx.doi.org/10.1038/nature07201] [PMID: 18650913]
[3]
Tabas, I.; Glass, C.K. Anti-inflammatory therapy in chronic disease: challenges and opportunities. Science, 2013, 339(6116), 166-172.
[http://dx.doi.org/10.1126/science.1230720] [PMID: 23307734]
[4]
Dietric, E.; Carris, N.; Panavelil, T.A. Anti-inflammatory, Antipyretic, and Analgesic Agents. In: Lippincott Illustrated Reviews: Pharmacology; Whalen, K.; Finkel, R.; Panavelil, T.A., Eds.; Wolters Kluwer: 6th ed. Philadelphia, 2015; p. 447.
[5]
Ricciotti, E.; FitzGerald, G.A. Prostaglandins and inflammation. Arterioscler. Thromb. Vasc. Biol., 2011, 31(5), 986-1000.
[http://dx.doi.org/10.1161/ATVBAHA.110.207449] [PMID: 21508345]
[6]
Hussain, T.; Tan, B.; Yin, Y.; Blachier, F.; Tossou, M.C.B.; Rahu, N. Oxidative stress and inflammation: what polyphenols can do for us? Oxid. Med. Cell. Longev., 2016, 2016, 7432797.
[http://dx.doi.org/10.1155/2016/7432797] [PMID: 27738491]
[7]
Dinarello, C.A. Anti-inflammatory agents: present and future. Cell, 2010, 140(6), 935-950.
[http://dx.doi.org/10.1016/j.cell.2010.02.043] [PMID: 20303881]
[8]
Marcum, Z.A.; Hanlon, J.T. Recognizing the risks of chronic nonsteroidal anti-inflammatory drug use in older adults. Ann. Longterm Care, 2010, 18(9), 24-27.
[PMID: 21857795]
[9]
Schneider, V.; Lévesque, L.E.; Zhang, B.; Hutchinson, T.; Brophy, J.M. Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: A population-based, nested case-control analysis. Am. J. Epidemiol., 2006, 164(9), 881-889.
[http://dx.doi.org/10.1093/aje/kwj331] [PMID: 17005625]
[10]
Gislason, G.H.; Rasmussen, J.N.; Abildstrom, S.Z.; Schramm, T.K.; Hansen, M.L.; Fosbøl, E.L.; Sørensen, R.; Folke, F.; Buch, P.; Gadsbøll, N.; Rasmussen, S.; Poulsen, H.E.; Køber, L.; Madsen, M.; Torp-Pedersen, C. Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure. Arch. Intern. Med., 2009, 169(2), 141-149.
[http://dx.doi.org/10.1001/archinternmed.2008.525] [PMID: 19171810]
[11]
Buettner, C.; Davis, R.B.; Leveille, S.G.; Mittleman, M.A.; Mukamal, K.J. Prevalence of musculoskeletal pain and statin use. J. Gen. Intern. Med., 2008, 23(8), 1182-1186.
[http://dx.doi.org/10.1007/s11606-008-0636-7] [PMID: 18449611]
[12]
Ramkumar, S.; Raghunath, A.; Raghunath, S. Statin therapy: review of safety and potential side effects. Acta Cardiol. Sin, 2016, 32(6), 631-639.
[PMID: 27899849]
[13]
Moghadam-Kia, S.; Werth, V.P. Prevention and treatment of systemic glucocorticoid side effects. Int. J. Dermatol., 2010, 49(3), 239-248.
[http://dx.doi.org/10.1111/j.1365-4632.2009.04322.x] [PMID: 20465658]
[14]
Bhutia, Y.D.; Vijayaraghavan, R.; Pathak, U. Analgesic and anti-inflammatory activity of amifostine, DRDE-07, and their analogs, in mice. Indian J. Pharmacol., 2010, 42(1), 17-20.
[http://dx.doi.org/10.4103/0253-7613.62401] [PMID: 20606831]
[15]
Damas, J.; Liégeois, J.F. The inflammatory reaction induced by formalin in the rat paw. Naunyn Schmiedebergs Arch. Pharmacol., 1999, 359(3), 220-227.
[http://dx.doi.org/10.1007/PL00005345] [PMID: 10208309]
[16]
Paiva, G.S.; Taft, C.A.; Carvalho, M.C.; de Souza, I.A.; da Silva, E.C.; Cavalcanti, K.P. L, R.F., Jr; De la Cruz, N.M. A comparative study of the effects of vitamins C and E in the development of sarcoma 180 in mice. J. Cancer, 2013, 4(9), 724-726.
[http://dx.doi.org/10.7150/jca.5921] [PMID: 24312142]
[17]
Silverstein, F.E.; Faich, G.; Goldstein, J.L.; Simon, L.S.; Pincus, T.; Whelton, A.; Makuch, R.; Eisen, G.; Agrawal, N.M.; Stenson, W.F.; Burr, A.M.; Zhao, W.W.; Kent, J.D.; Lefkowith, J.B.; Verburg, K.M.; Geis, G.S. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA, 2000, 284(10), 1247-1255.
[http://dx.doi.org/10.1001/jama.284.10.1247] [PMID: 10979111]
[18]
de Kruif, M.D.; Lemaire, L.C.; Giebelen, I.A.; van Zoelen, M.A.D.; Pater, J.M.; van den Pangaart, P.S.; Groot, A.P.; de Vos, A.F.; Elliott, P.J.; Meijers, J.C.M.; Levi, M.; van der Poll, T. Prednisolone dose-dependently influences inflammation and coagulation during human endotoxemia. J. Immunol., 2007, 178(3), 1845-1851.
[http://dx.doi.org/10.4049/jimmunol.178.3.1845] [PMID: 17237435]
[19]
Sparrow, C.P.; Burton, C.A.; Hernandez, M.; Mundt, S.; Hassing, H.; Patel, S.; Rosa, R.; Hermanowski-Vosatka, A.; Wang, P.R.; Zhang, D.; Peterson, L.; Detmers, P.A.; Chao, Y.S.; Wright, S.D. Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering. Arterioscler. Thromb. Vasc. Biol., 2001, 21(1), 115-121.
[http://dx.doi.org/10.1161/01.ATV.21.1.115] [PMID: 11145942]
[20]
Abbas, S.S.; Schaalan, M.F.; Bahgat, A.K.; El-Denshary, E.S. Possible potentiation by certain antioxidants of the anti-inflammatory effects of diclofenac in rats. Sci. World J., 2014, 2014, 731462.
[http://dx.doi.org/10.1155/2014/731462] [PMID: 24715817]
[21]
Osafo, N.; Agyare, C.; Obiri, D.D.; Antwi, A.O. Mechanism of action of nonsteroidal anti-inflammatory drugs In: Nonsteroidal Anti-inflamm Drugs 2017; https://www.intechopen.com/books/nonsteroidal-anti-inflammatory-drugs/mechanism-of-action-of-nonsteroidal-anti-inflammatory-drugs
[http://dx.doi.org/10.5772/68090]
[22]
Antonopoulos, A.S.; Margaritis, M.; Lee, R.; Channon, K.; Antoniades, C. Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials. Curr. Pharm. Des., 2012, 18(11), 1519-1530.
[http://dx.doi.org/10.2174/138161212799504803] [PMID: 22364136]
[23]
Coutinho, A.E.; Chapman, K.E. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol. Cell. Endocrinol., 2011, 335(1), 2-13.
[http://dx.doi.org/10.1016/j.mce.2010.04.005] [PMID: 20398732]
[24]
Khan, S.I.; Saha, S.K.; Poddar, S.K.; Bachar, R.; Shoyaib, A.A.; Chakrabarty, J.K.; Promite, S.; Bachar, S.C.; Pal, T.K. Bioequivalence studies and pharmacokinetic properties of atorvastatin 40 mg tablet in healthy Bengali subjects. J. Bioequivalence Bioavailab., 2017, 4, 241-246.
[25]
McGinnis, S.; Madden, T.L. BLAST: at the core of a powerful and diverse set of sequence analysis tools. Nucleic Acids Res., 2004, 32(Web Server issue), W20-W25.
[http://dx.doi.org/10.1093/nar/gkh435]
[26]
Greene, E.L.; Velarde, V.; Jaffa, A.A. Role of reactive oxygen species in bradykinin-induced mitogen-activated protein kinase and c-fos induction in vascular cells. Hypertension, 2000, 35(4), 942-947.
[http://dx.doi.org/10.1161/01.HYP.35.4.942] [PMID: 10775566]


open access plus

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 19
ISSUE: 3
Year: 2020
Published on: 03 September, 2020
Page: [291 - 301]
Pages: 11
DOI: 10.2174/1871523018666190514112048

Article Metrics

PDF: 29
HTML: 1